Expands Long-Term Relationship Providing Amorphous Silicon Digital X-Ray Detectors

BOSTON—PerkinElmer, Inc. (NYSE: PKI) today announced the signing of a long-term, exclusive agreement with General Electric Corporation (NYSE: GE) to supply PerkinElmer's amorphous silicon digital flat panel X-Ray detector technology to GE Medical Systems (GEMS) and GE Aircraft Engines (GEAE). This agreement marks a major milestone in PerkinElmer's six-year relationship with GEMS, as the exclusive supplier of digital X-Ray detectors for advanced medical imaging and industrial applications. Under the agreement, PerkinElmer Optoelectronics will be sole provider of this technology to GEMS and GEAE for the next five years, a deal estimated to include more than $250 million of purchases by GE.

PerkinElmer's amorphous silicon X-Ray detectors provide detailed radiographic and fluoroscopic images of the human anatomy in digital form, offering physicians the highest sensitivity of detection and resolution during medical procedures. X-Ray signals are converted into digital images, providing exceptional image clarity with a large field of view for clinical applications that require exact precision, such as, radiography, cardiology and angiography procedures. As hospitals and clinics continue to switch from film-based to digital X-Ray, demand for GE's systems utilizing amorphous silicon detectors will continue to grow. This technology also is a key driver in opening up market opportunities in non-destructive testing, and has potential application in areas such as homeland security and biometric identification.

"Digital X-ray technology increases the ability to not only capture, store and retrieve images, but improve the diagnosis and treatment process for patients worldwide," said Joe Hogan, president and CEO of GEMS. "We look forward to building upon our strong industry-leading relationship with PerkinElmer as digital X-ray becomes the standard in healthcare."

"We are very pleased to continue our strong relationship with GE, and remain dedicated to providing the best digital imaging technology available today," said Greg Summe, chairman and CEO, PerkinElmer, Inc. "GEMS sets the pace in imaging technology, enabling healthcare providers with the best tools available, to improve the quality of life worldwide."

PerkinElmer Optoelectronics became a supplier of digital medical X-Ray detectors to GEMS in 1997, and has delivered more than 1,500 detectors to GEMS. As hospitals continue to expand their digital capabilities, GEMS has expanded its biomedical and digital imaging technology portfolio to meet this growing demand.

General Electric Company, headquartered in Fairfield, CT, is a diversified technology and services company dedicated to creating products that make life better from aircraft engines and power generation to financial services, medical imaging, television broadcasting and plastics. GE Company operates in more than 100 countries and employs more than 315,000 people worldwide, including approximately 75,000 in Europe.

GE Medical Systems is a global leader in medical imaging, healthcare services and information technology. Its offerings include networking and productivity tools, clinical information systems, patient monitoring systems, surgery and vascular imaging, conventional and digital X-Ray, computed tomography, electron beam computed tomography, magnetic resonance, ultrasound and bone mineral densitometry, positron emission tomography, nuclear medicine and a full line of clinical and business services. For more than 100 years, health-care providers worldwide have relied on GE Medical Systems for high quality medical technology and productivity solutions. GE Medical Systems operates in more than 100 countries and employs more than 30,000 people worldwide.

GE Aircraft Engines (GEAE), a division of General Electric Company (NYSE: GE), is the world's leading manufacturer of jet engines for civil and military aircraft, including engines produced by CFM International, a 50/50 joint company of Snecma Moteurs and GE. GEAE also manufactures gas turbines, derived from its highly successful jet engine programs, for marine and industrial applications. In addition, GEAE provides comprehensive maintenance support, through its GE Engine Services operation, for GE and non-GE jet engines in service throughout the world. Visit GEAE online at: http://www.geae.com.

Factors Affecting Future Performance

This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) fluctuations in the global economic and political environments; (4) markets into which we sell our products decline or do not grow as anticipated; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply of raw materials and supplies; (11) our ability to produce an adequate quantity of products to meet our customers' demands; (12) the manufacture and sale of products may expose us to product liability claims; (13) our failure to maintain compliance with applicable government regulations; (14) regulatory changes; (15) our failure to comply with health care industry regulations; (16) economic, political and other risks associated with foreign operations; (17) our ability to retain key personnel; (18) restrictions in our credit agreements; (19) our ability to realize the full value of our intangible assets; (20) significant fluctuations in our stock price; and (21) other factors which we describe under the caption "Risk Factors" in our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2 billion in 2008, has around 8,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.

		For Further Information:
		Media Contact: Kristen Kmetetz Porter Novelli Life Sciences 617.897.8272 (office) Kristen.kmetetz@porternovelli.com or Francine S. Bernitz Marketing Director, Illumination and Detection Solutions PerkinElmer, Inc. Francine.bernitz@perkinelmer.com 978.224.4321 (office) 781.789.3178 (cell)